📣 VC round data is live. Check it out!

Dis-Chem Pharmacies Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dis-Chem Pharmacies and similar public comparables like Omnicell, LBX Pharmacy, Kusuri No Aoki, Selçuk Ecza and more.

Dis-Chem Pharmacies Overview

About Dis-Chem Pharmacies

Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.


Founded

1978

HQ

South Africa

Employees

20.6K

Sectors

Financials (LTM)

Revenue: $3B
EBITDA: $211M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dis-Chem Pharmacies Financials

Dis-Chem Pharmacies reported last 12-month revenue of $3B and EBITDA of $211M.

In the same LTM period, Dis-Chem Pharmacies generated $607M in gross profit, $211M in EBITDA, and $78M in net income.

Revenue (LTM)


Dis-Chem Pharmacies P&L

In the most recent fiscal year, Dis-Chem Pharmacies reported revenue of $2B and EBITDA of $197M.

Dis-Chem Pharmacies is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 8%, and net margin of 3%.

See analyst estimates for Dis-Chem Pharmacies
LTMLast FY202320242025202620272028
Revenue$3B$2B$2B$2B$3B
Gross Profit$607M$526M$485M$521M$580M
Gross Margin23%22%23%22%23%
EBITDA$211M$197M$173M$194M$205M
EBITDA Margin8%8%8%8%8%
EBIT Margin5%5%(3%)(3%)4%
Net Profit$78M$71M$59M$69M$75M
Net Margin3%3%3%3%3%
Net Debt$179M

Financial data powered by Morningstar, Inc.

Dis-Chem Pharmacies Stock Performance

Dis-Chem Pharmacies has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Dis-Chem Pharmacies' stock price is $2.18.

Dis-Chem Pharmacies share price increased by 0.6% in the last 30 days, and by 8.9% in the last year.

Dis-Chem Pharmacies has an EPS (earnings per share) of $0.08.

See more trading valuation data for Dis-Chem Pharmacies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B-0.2%0.6%-3.3%8.9%$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dis-Chem Pharmacies Valuation Multiples

Dis-Chem Pharmacies trades at 0.8x EV/Revenue multiple, and 10.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Dis-Chem Pharmacies

EV / Revenue (LTM)


Dis-Chem Pharmacies Financial Valuation Multiples

As of May 4, 2026, Dis-Chem Pharmacies has market cap of $2B and EV of $2B.

Dis-Chem Pharmacies has a P/E ratio of 24.1x.

LTMLast FY202320242025202620272028
EV/Revenue0.8x0.9x1.0x0.9x0.9x
EV/EBITDA10.3x11.0x12.6x11.2x10.6x
EV/EBIT16.0x18.6x(37.9x)(33.0x)21.9x
EV/Gross Profit3.6x4.1x4.5x4.2x3.7x
P/E24.1x26.5x31.7x27.3x25.1x
EV/FCF33.9x(73.0x)111.3x(106.3x)49.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dis-Chem Pharmacies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dis-Chem Pharmacies Margins & Growth Rates

Dis-Chem Pharmacies grew revenue by 10% and EBITDA by 4% in the last fiscal year.

In the most recent fiscal year, Dis-Chem Pharmacies reported gross margin of 22%, EBITDA margin of 8%, and net margin of 3%.

See estimated margins and future growth rates for Dis-Chem Pharmacies

Dis-Chem Pharmacies Margins

Last FY202420252026202720282029
Gross Margin22%22%23%24%
EBITDA Margin8%8%8%8%
EBIT Margin5%(3%)4%5%
Net Margin3%3%3%3%
FCF Margin(1%)(1%)2%3%

Dis-Chem Pharmacies Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%8%10%10%
Gross Profit Growth12%7%11%15%
EBITDA Growth4%12%6%12%
EBIT Growth13%15%(251%)49%
Net Profit Growth7%16%9%16%
FCF Growth(297%)(205%)(314%)92%

Data powered by FactSet, Inc. and Morningstar, Inc.

Dis-Chem Pharmacies Operational KPIs

Dis-Chem Pharmacies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Dis-Chem Pharmacies' Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dis-Chem Pharmacies' Rule of X is 33% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dis-Chem Pharmacies
LTMLast FY202320242025202620272028
Rule of 4018%18%
Bessemer Rule of X33%33%
Revenue per Employee$0.1M
Opex per Employee$0.0M
S&M Expenses to Revenue2%2%2%1%
G&A Expenses to Revenue1%1%1%1%
Opex to Revenue25%25%25%23%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dis-Chem Pharmacies Competitors

Dis-Chem Pharmacies competitors include Omnicell, LBX Pharmacy, Kusuri No Aoki, Selçuk Ecza, Create SD Holdings, AiN Group, Anhui Huaren Health, Ebos Group, Redcare Pharmacy and Medplus Health Services.

Most Dis-Chem Pharmacies public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Omnicell1.6x1.6x13.6x12.9x
LBX Pharmacy0.6x0.5x5.3x5.6x
Kusuri No Aoki0.8x0.8x10.4x10.9x
Selçuk Ecza0.3x0.3x10.3x8.1x
Create SD Holdings0.4x0.4x6.4x
AiN Group0.7x0.5x9.7x6.5x
Anhui Huaren Health1.6x13.3x
Ebos Group0.5x0.4x10.7x8.4x

This data is available for Pro users. Sign up to see all Dis-Chem Pharmacies competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dis-Chem Pharmacies

When was Dis-Chem Pharmacies founded?Dis-Chem Pharmacies was founded in 1978.
Where is Dis-Chem Pharmacies headquartered?Dis-Chem Pharmacies is headquartered in South Africa.
How many employees does Dis-Chem Pharmacies have?As of today, Dis-Chem Pharmacies has over 20K employees.
Who is the CEO of Dis-Chem Pharmacies?Dis-Chem Pharmacies' CEO is Rui Manuel Morais.
Is Dis-Chem Pharmacies publicly listed?Yes, Dis-Chem Pharmacies is a public company listed on Johannesburg Stock Exchange.
What is the stock symbol of Dis-Chem Pharmacies?Dis-Chem Pharmacies trades under DCP ticker.
When did Dis-Chem Pharmacies go public?Dis-Chem Pharmacies went public in 2016.
Who are competitors of Dis-Chem Pharmacies?Dis-Chem Pharmacies main competitors include Omnicell, LBX Pharmacy, Kusuri No Aoki, Selçuk Ecza, Create SD Holdings, AiN Group, Anhui Huaren Health, Ebos Group, Redcare Pharmacy, Medplus Health Services.
What is the current market cap of Dis-Chem Pharmacies?Dis-Chem Pharmacies' current market cap is $2B.
What is the current revenue of Dis-Chem Pharmacies?Dis-Chem Pharmacies' last 12 months revenue is $3B.
What is the current revenue growth of Dis-Chem Pharmacies?Dis-Chem Pharmacies revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of Dis-Chem Pharmacies?Current revenue multiple of Dis-Chem Pharmacies is 0.8x.
Is Dis-Chem Pharmacies profitable?Yes, Dis-Chem Pharmacies is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Dis-Chem Pharmacies?Dis-Chem Pharmacies' last 12 months EBITDA is $211M.
What is Dis-Chem Pharmacies' EBITDA margin?Dis-Chem Pharmacies' last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Dis-Chem Pharmacies?Current EBITDA multiple of Dis-Chem Pharmacies is 10.3x.
What is the current FCF of Dis-Chem Pharmacies?Dis-Chem Pharmacies' last 12 months FCF is $64M.
What is Dis-Chem Pharmacies' FCF margin?Dis-Chem Pharmacies' last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Dis-Chem Pharmacies?Current FCF multiple of Dis-Chem Pharmacies is 33.9x.
How many companies Dis-Chem Pharmacies has acquired to date?Dis-Chem Pharmacies hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Dis-Chem Pharmacies has invested to date?Dis-Chem Pharmacies hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Dis-Chem Pharmacies

Lists including Dis-Chem Pharmacies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial